학술논문

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
Document Type
article
Author
Hirschfeld, Cole BShaw, Leslee JWilliams, Michelle CLahey, RyanVillines, Todd CDorbala, SharmilaChoi, Andrew DShah, Nishant RBluemke, David ABerman, Daniel SBlankstein, RonFerencik, MarosNarula, JagatWinchester, DavidMalkovskiy, EliGoebel, BenjaminRandazzo, Michael JLopez-Mattei, JuanParwani, PurviVitola, Joao VCerci, Rodrigo JBetter, NathanRaggi, PaoloLu, BinSergienko, VladimirSinitsyn, ValentinKudo, TakashiNørgaard, Bjarne LindeMaurovich-Horvat, PálCohen, Yosef APascual, Thomas NBPynda, YaroslavDondi, MaurizioPaez, DianaEinstein, Andrew JCerci, RodrigoHinterleitner, GerdLu, YaoMorozova, OlgaXu, ZhuoranCohen, YosefRandazzo, MichaelChoi, AndrewNasery, Mohammad NawazGoda, ArtanShirka, ErvinaBenlabgaa, RabieBouyoucef, SalahMedjahedi, AbdelkaderNailli, QaisAgolti, MarielaAguero, Roberto Nicolasdel Carmen Alak, MariaAlberguina, Lucia GracielaArroñada, GuillermoAstesiano, AndreaAstesiano, AlfredoNorton, Carolina BasBenteo, PabloBlanco, JuanBonelli, Juan ManuelBustos, Jose JavierCabrejas, RaulCachero, JorgeCampisi, RoxanaCanderoli, AlejandroCarames, SilviaCarrascosa, PatríciaCastro, RicardoCendoya, OscarCognigni, Luciano MartinCollaud, CarlosCortes, ClaudiaCourtis, JavierCragnolino, DanielDaicz, MarianaDe La Vega, AlejandroDe Maria, Silvia TeresaDel Riego, HoracioDettori, FernandoDeviggiano, AlejandroDragonetti, Laura
Source
JACC Cardiovascular Imaging. 14(9)
Subject
Heart Disease
Clinical Research
Health Services
Prevention
Aging
Cardiovascular
Good Health and Well Being
COVID-19
COVID-19 Testing
Humans
Pandemics
Predictive Value of Tests
SARS-CoV-2
United States
cardiovascular disease
cardiovascular imaging
coronavirus
diagnostic cardiovascular procedure
INCAPS-COVID Investigators Group
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Cardiovascular System & Hematology
Language
Abstract
ObjectivesThis study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.BackgroundThe COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.MethodsData were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.ResultsReductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p